Innovative Medical's Investee Bolin Brain-Computer Interface Begins In Vivo Testing in Patients

Zhejiang Shanxiahu Pearl Group Co.,Ltd. recently stated in a research report that Cereblink (Hangzhou) Technology Co., Ltd., in which it has invested, has achieved the upgrading of its prototype in the past year and has begun in vivo testing on patients, making certain progress.